​

IDEAYA Biosciences (IDYA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

IDEAYA Biosciences Revenue Highlights

Latest Revenue (Y)

$23.39M

0

Main Segment (Y)

Methionine Adenosyl Transferase2 A Program Supply

IDEAYA Biosciences Revenue by Period

IDEAYA Biosciences Revenue by Year

DateRevenueChange
2023-12-31$23.39M-54.08%
2022-12-31$50.93M82.28%
2021-12-31$27.94M43.01%
2020-12-31$19.54M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

IDEAYA Biosciences generated $23.39M in revenue during NA 2023, up -54.08% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

IDEAYA Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$3.92M-51.19%
2023-09-30$8.04M126.81%
2023-06-30$3.54M-55.03%
2023-03-31$7.88M95.92%
2022-12-31$4.02M-86.46%
2022-09-30$29.70M407.59%
2022-06-30$5.85M-48.49%
2022-03-31$11.36M283.36%
2021-12-31$2.96M-66.99%
2021-09-30$8.98M2.51%
2021-06-30$8.76M20.82%
2021-03-31$7.25M-31.44%
2020-12-31$10.57M17.89%
2020-09-30$8.97M100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

IDEAYA Biosciences generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

IDEAYA Biosciences Revenue Breakdown

IDEAYA Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20
Methionine Adenosyl Transferase2 A Program Supply$2.40M$2.41M$2.35M
Methionine Adenosyl Transferase2 A Program Research And Development-$9.49M$16.14M
Polymerase Theta Program Research And Development Service-$13.75M$25.78M
The Option-$17.68M$17.23M
Werner Helicase Program Research And Development Service-$20.83M$27.79M

IDEAYA Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: Methionine Adenosyl Transferase2 A Program Supply (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 23Jun 23Mar 23Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21
Werner Helicase Program Research And Development Service$1.44M$2.82M$6.25M$16.06M$18.16M$19.09M$22.39M$23.78M$25.69M
Polymerase Theta Program Research And Development Service---$2.12M$10.00M$11.27M$12.76M$17.32M$22.39M
Methionine Adenosyl Transferase 2 A Option Member----$17.47M$17.49M---
Methionine Adenosyl Transferase2 A Program Research And Development-----$3.78M$10.29M$13.02M$14.77M
The Option------$17.37M$17.32M$17.31M
Methionine Adenosyl Transferase2 A Program Supply------$2.37M$2.36M$2.36M

IDEAYA Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Werner Helicase Program Research And Development Service (100.00%).

IDEAYA Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
PTGXProtagonist Therapeutics$60.00M$4.67M
IDYAIDEAYA Biosciences$23.39M-
ANABAnaptysBio$17.16M$30.02M
MGTXMeiraGTx$14.02M$10.91M
RVMDRevolution Medicines$11.58M-
RNAAvidity Biosciences$9.56M$2.04M
SWTXSpringWorks Therapeutics$5.45M$59.73M
KROSKeros Therapeutics$151.00K$37.00K
XFORX4 Pharmaceuticals-$560.00K
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
VRNAVerona Pharma-$5.62M
SNDXSyndax Pharmaceuticals-$12.50M
TERNTerns Pharmaceuticals--
VTYXVentyx Biosciences--
MLTXMoonLake Immunotherapeutics--

IDYA Revenue FAQ

What is IDEAYA Biosciences’s yearly revenue?

IDEAYA Biosciences's yearly revenue for 2023 was $23.38M, representing a decrease of -54.08% compared to 2022. The company's yearly revenue for 2022 was $50.93M, representing an increase of 82.28% compared to 2021. IDYA's yearly revenue for 2021 was $27.94M, representing an increase of 43.01% compared to 2020.

What is IDEAYA Biosciences’s quarterly revenue?

IDEAYA Biosciences's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). IDYA's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is IDEAYA Biosciences’s revenue growth rate?

IDEAYA Biosciences's revenue growth rate for the last 3 years (2021-2023) was -16.31%, and for the last 5 years (2019-2023) was 0%.

What are IDEAYA Biosciences’s revenue streams?

IDEAYA Biosciences's revenue streams in c 22 are Methionine Adenosyl Transferase2 A Program Supply

What is IDEAYA Biosciences’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of IDEAYA Biosciences was Methionine Adenosyl Transferase2 A Program Supply. This segment made a revenue of $2.4M, representing 100.00% of the company's total revenue.